Company news

Cel-sci Corporation (AMEX:CVM) news

Every Cel-sci Corporation press release and news update in one place — announcements, filings coverage, and company updates for investors.

View Cel-sci Corporation stock analysis →

Press releases & updates

CEL-SCI Reports Fiscal Second Quarter 2026 Results

May 18, 2026

CEL-SCI Corporation Announces Pricing of Public Offering

May 11, 2026

CEL-SCI Enters Strategic Agreement with Amarox for the Registration, Commercialization, and Distribution of Multikine in Saudi Arabia

May 11, 2026

CEL-SCI Reports Fiscal First Quarter 2026 Results

February 18, 2026

CEL-SCI Reports Fiscal 2025 Results

December 29, 2025

CEL-SCI Presentation at LD Micro "Main Event" Available on Tuesday, October 21, 2025

October 20, 2025

CEL-SCI Corporation to Present at LD Micro "Main Event" Investor Conference

October 10, 2025

CEL-SCI Announces Closing of $10 Million Public Offering

August 29, 2025

CEL-SCI Announces Pricing of $10 Million Public Offering

August 27, 2025

CEL-SCI Announces Proposed Public Offering

August 27, 2025

CEL-SCI Reports Fiscal Third Quarter 2025 Financial Results

August 14, 2025

CEL-SCI’s Multikine Head and Neck Cancer Immunotherapy Breakthrough Medicine Designation Filed in Saudi Arabia: Allows for Patient Access...

August 13, 2025

CEL-SCI Announces Closing of $5.7 Million Offering Priced At-The-Market Under NYSE American Rules

July 14, 2025

CEL-SCI Announces Pricing of $5.7 Million Offering Priced At-the-Market Under NYSE American Rules

July 11, 2025

CEL-SCI to Sign Partnership Agreement With Leading Saudi Arabian Pharma Company for Multikine in the Treatment of Head & Neck Cancer

July 11, 2025

CEL-SCI Announces Closing of Public Offering

May 23, 2025

CEL-SCI Announces Pricing of Public Offering

May 21, 2025

CEL-SCI’s Multikine Investigational Cancer Medicine Potentially Available for Commercialization by Summer 2025 in Saudi Arabia

May 21, 2025

CEL-SCI Announces Combination of Common Stock

May 19, 2025

CEL-SCI Reports Fiscal Second Quarter 2025 Financial Results

May 15, 2025

CEL-SCI to File for Regulatory Approval of Multikine in Saudi Arabia—Pursuing Local Partnerships for Commercialization and Manufacturing ...

April 23, 2025